4/A//SEC Filing
Viney Joanne L. 4/A
Accession 0001209191-21-032974
CIK 0001708493other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 8:09 PM ET
Size
8.9 KB
Accession
0001209191-21-032974
Insider Transaction Report
Form 4/AAmended
Viney Joanne L.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 totalExercise: $23.20Exp: 2031-05-03→ Common Stock (10,167 underlying) - Award
Director Stock Option (Right to Buy)
2021-05-04+2,571→ 2,571 totalExercise: $23.20Exp: 2031-05-03→ Common Stock (2,571 underlying)
Footnotes (5)
- [F1]This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error.
- [F2]The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022.
- [F3]This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error related to the calculation date of the Black-Scholes value.
- [F4]The number of shares underlying the option was erroneously reported as 2,653 on the original Form 4 filed on May 7, 2021 due to an administrative error related to the calculation date of the Black-Scholes value.
- [F5]50% of the shares subject to the option are fully vested and exercisable, and 25% will vest and become exercisable on September 30, 2021 and December 31, 2021, subject to the continuous service of the Reporting Person on each vesting date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001816744
Filing Metadata
- Form type
- 4/A
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 8:09 PM ET
- Size
- 8.9 KB